Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Revenue (2020 - 2025)

IDEAYA Biosciences' Revenue history spans 6 years, with the latest figure at $10.9 million for Q4 2025.

  • For Q4 2025, Revenue rose 55.37% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, up 55.37%, while the annual FY2025 figure was $218.7 million, 3024.43% up from the prior year.
  • Revenue for Q4 2025 was $10.9 million at IDEAYA Biosciences, up from $7.0 million in the prior quarter.
  • Across five years, Revenue topped out at $29.7 million in Q3 2022 and bottomed at $3.0 million in Q4 2021.
  • The 5-year median for Revenue is $7.6 million (2021), against an average of $8.6 million.
  • The largest annual shift saw Revenue skyrocketed 230.87% in 2022 before it crashed 72.94% in 2023.
  • A 5-year view of Revenue shows it stood at $3.0 million in 2021, then skyrocketed by 35.79% to $4.0 million in 2022, then dropped by 2.46% to $3.9 million in 2023, then surged by 78.43% to $7.0 million in 2024, then skyrocketed by 55.37% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Revenue are $10.9 million (Q4 2025), $7.0 million (Q4 2024), and $3.9 million (Q4 2023).